Article
Treatment of congenital fibrinogen disorders.
Expert opinion on biological therapy - 1 Jul 2008
de Moerloose Philippe, Neerman-Arbez Marguerite
Abstract excerpt
BACKGROUND: The goal of the coagulation pathway is the conversion of fibrinogen to fibrin and formation of an insoluble clot. Although relatively rare, congenital fibrinogen disorders are interesting and pose several challenges that can serve as paradigms for many diseases. An impressive body of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
